- Home
- ELWS vs NLSP Comparison
ELWS vs NLSP Comparison
Compare ELWS & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- NLSP
- Stock Information
- Founded
- ELWS 2018
- NLSP 2015
- Country
- ELWS Japan
- NLSP Switzerland
- Employees
- ELWS N/A
- NLSP N/A
- Industry
- ELWS
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- NLSP Health Care
- Exchange
- ELWS Nasdaq
- NLSP Nasdaq
- Market Cap
- ELWS 6.2M
- NLSP 6.2M
- IPO Year
- ELWS 2023
- NLSP 2021
- Fundamental
- Price
- ELWS $2.57
- NLSP $1.95
- Analyst Decision
- ELWS
- NLSP
- Analyst Count
- ELWS 0
- NLSP 0
- Target Price
- ELWS N/A
- NLSP N/A
- AVG Volume (30 Days)
- ELWS 15.5K
- NLSP 6.1M
- Earning Date
- ELWS 12-31-2024
- NLSP 10-18-2024
- Dividend Yield
- ELWS N/A
- NLSP N/A
- EPS Growth
- ELWS N/A
- NLSP N/A
- EPS
- ELWS N/A
- NLSP N/A
- Revenue
- ELWS $1,139,113.00
- NLSP N/A
- Revenue This Year
- ELWS N/A
- NLSP N/A
- Revenue Next Year
- ELWS N/A
- NLSP N/A
- P/E Ratio
- ELWS N/A
- NLSP N/A
- Revenue Growth
- ELWS 285.14
- NLSP N/A
- 52 Week Low
- ELWS $1.04
- NLSP $1.71
- 52 Week High
- ELWS $8.68
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- ELWS 38.57
- NLSP 44.06
- Support Level
- ELWS $2.75
- NLSP $2.14
- Resistance Level
- ELWS $2.92
- NLSP $2.34
- Average True Range (ATR)
- ELWS 0.23
- NLSP 0.24
- MACD
- ELWS -0.06
- NLSP -0.00
- Stochastic Oscillator
- ELWS 2.09
- NLSP 12.07
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.